Categories: 3DAnalyticsDiagnosticsEngineeringLifeMarketMedtechPlatformRoboticsTechnology
IMAI Medtech is on a mission to redefine the landscape of oncology diagnostics through its pioneering 3D histology technology. By focusing on the early and accurate diagnosis of cancer, IMAI aims to enhance therapeutic outcomes and significantly improve patient care.
Investors 1
Mentions in press and media 3
| Date | Title | Description |
| 08.07.2024 | New portfolio companies for S2S Ventures |
Designed for student entrepreneurs, S2S Ventures is an independent Students-2-Students venture capital fund offering CHF 25,000 in start-ups founded at Swiss institutions of higher education and provide them with personalized feedback and ... |
| 23.02.2024 | Progressing towards market entry with InnoBooster |
The InnoBooster program is an initiative of the Gebert Rüf Stiftung that provides university-based high-potential projects with a grant of CHF 150’000 to support the development of their solution. The new selection this year includes four ... |
| - | IMAI MedTech | “IMAI Medtech is on a mission to redefine the landscape of oncology diagnostics through its pioneering 3D histology technology. By focusing on the early and accurate diagnosis of cancer, IMAI aims to enhance therapeutic outcomes and signifi... |
Reviews 0
